Victor L. Villemagne

Research interests

Publications

• Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

  Nature Medicine · 2023 · https://doi.org/10.1038/s41591-023-02380-x

• Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease

  Molecular Psychiatry · 2022 · https://doi.org/10.1038/s41380-022-01716-2

• Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

  Alzheimer s & Dementia · 2022 · https://doi.org/10.1002/alz.12724

• Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

  Translational Psychiatry · 2021 · https://doi.org/10.1038/s41398-020-01137-1

• The Amyloid-β Pathway in Alzheimer’s Disease

  Molecular Psychiatry · 2021 · 10.1038/s41380-021-01249-0

• Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

  The Lancet Neurology · 2020 · https://doi.org/10.1016/s1474-4422(20)30314-8

• Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease

  Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-12242-1

• Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts

  Alzheimer s & Dementia · 2018 · https://doi.org/10.1016/j.jalz.2018.04.010

• Multisite study of the relationships between antemortem [ 11 C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

  Alzheimer s & Dementia · 2018 · https://doi.org/10.1016/j.jalz.2018.09.001

• Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia

  Annals of Neurology · 2018 · https://doi.org/10.1002/ana.25333

• Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

  JAMA Psychiatry · 2017 · https://doi.org/10.1001/jamapsychiatry.2017.3391

• Prevalence of Amyloid PET Positivity in Dementia Syndromes

  JAMA · 2015 · https://doi.org/10.1001/jama.2015.4669

• Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

  The Lancet Neurology · 2013 · https://doi.org/10.1016/s1474-4422(13)70044-9

• Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease

  Proceedings of the National Academy of Sciences · 2013 · https://doi.org/10.1073/pnas.1317918110

• 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

  Brain · 2011 · https://doi.org/10.1093/brain/awr038

• The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

  International Psychogeriatrics · 2009 · https://doi.org/10.1017/s1041610209009405

• Imaging β-amyloid burden in aging and dementia

  Neurology · 2007 · https://doi.org/10.1212/01.wnl.0000261919.22630.ea

Current projects

No projects listed.